Insight Capital
VC Fund
Beijing, China
Insight Capital is a venture capital firm focused on early-stage investment.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 37%
- Fund size:
- $74M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Insight Capital invests in
Stages Insight Capital invests in
Countries Insight Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $14M–$15M
- Series A
- $2.8M–$14M
- Series B
- $15M–$65M
Investment Focus
Industry
- Health Care 12 (44%)
- Medical 11 (41%)
- Medical Device 5 (19%)
- Biotechnology 4 (15%)
- Software 2 (7%)
Stage
- Series A 12 (44%)
- Seed 4 (15%)
- Series B 4 (15%)
- Series C 4 (15%)
- Venture - Series Unknown 2 (7%)
Country
- China 19 (70%)
- Thailand 1 (4%)
- United Kingdom 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Krista Matheson
CEO & Founder
|
CEO & Founder | Total investments: 0 | Find email | |
|
Cong Bo
Vice President
|
Vice President | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Hangzhou Dasheng Technology
|
Hangzhou Dasheng is a high-tech enterprise specializing in the research and development of medical surgical robot systems, dedicated to advancing precision medicine through innovative technologies, integrating artificial intelligence, robotics, and minimally invasive surgical solutions to improve clinical outcomes, enhance surgeon capabilities, andprovide safer, more efficient healthcare services worldwide. | Seed / Mar 31, 2026 | |
|
Rigato Medical Technology
|
Rigato Medical Technology focuses on the R&D and production of medical devices and supplies. | Series A / Feb 04, 2026 | |
|
Sieran Medical
|
Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology. | $14M / Venture - Series Unknown / Sep 02, 2025 | |
Iongen Therepeutics
|
Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment. | $15M / Seed / Jan 15, 2025 | |
Sigma Squares Tech
|
Sigma Squares Tech is an automated manufacturing system developer. | Series B / Oct 17, 2024 | |
|
Sieran Medical
|
Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology. | $14.1M / Seed / Sep 05, 2024 | |
Amity Solutions
|
Amity Solutions is a software company that offers employee engagement solutions for chatbots, AI platforms, and customers. | $41.6M / Venture - Series Unknown / Jul 16, 2024 | |
Amity Corporation
|
The future is social — and Amity is on a mission to make social experiences more accessible than ever. Amity's technology powers digital communities, enabling users to connect with like-minded people and find a sense of belonging.Amity Social Cloud, the company’s flagship platform, allows developers to easily add plug-and-play socialfeatures to any app or digital platform. In a booming and crowded mobile app marketplace, this enables product and marketing teams to drive engagement, build communities, increase retention and grow revenues.Amity’s platform is used by more than 10 million people every month, powering in-app social experiences and social networks for hundreds of customers operating in many different industries, ranging from sport, media, retail, to banking and education. Notable clients include industry-leading enterprises such as AirAsia, True Corporation, and Unilever.Amity currently has over 200 employees spread across offices in Bangkok, London, Milan, and Miami. | $60M / Series C / Jul 16, 2024 | |
LeadBio Tech
|
LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices. | $13.7M / Series A / Nov 13, 2023 | |
Yaoshi Medical
|
Yaoshi Medical conducts research and development in the field of ocular illness diagnosis and screening equipment. | Series A / Jun 12, 2023 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Insight Capital invest in?
Insight Capital invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Seed stage. Most of the 27 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Insight Capital's check size?
Insight Capital typically joins rounds of $14M–$15M at Seed, $2.8M–$14M at Series A and $15M–$65M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Insight Capital participates in.
How do I contact Insight Capital?
Public channels for Insight Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Insight Capital?
The team at Insight Capital includes Krista Matheson (CEO & Founder) and Cong Bo (Vice President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
